Harmony Biosciences Holdings, Inc. (HRMY)
39.64
+0.07
(+0.18%)
USD |
NASDAQ |
Oct 02, 16:00
39.64
0.00 (0.00%)
After-Hours: 20:00
Harmony Biosciences Holdings Price : 39.64 for Oct. 2, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 02, 2026 | 39.78 | 40.62 | 39.25 | 39.64 | 916733.0 |
| Oct 01, 2026 | 39.58 | 40.46 | 39.08 | 39.57 | 1.228M |
| Sep 30, 2026 | 39.30 | 39.56 | 38.72 | 39.26 | 667692.0 |
| Sep 29, 2026 | 39.87 | 40.52 | 39.15 | 39.29 | 786676.0 |
| Sep 28, 2026 | 41.29 | 41.54 | 39.54 | 40.01 | 874387.0 |
| Sep 25, 2026 | 41.37 | 41.60 | 40.89 | 41.26 | 557011.0 |
| Sep 24, 2026 | 40.63 | 41.79 | 40.00 | 41.16 | 906463.0 |
| Sep 23, 2026 | 41.61 | 42.08 | 39.72 | 40.48 | 1.081M |
| Sep 22, 2026 | 42.10 | 42.37 | 41.36 | 41.53 | 577958.0 |
| Sep 21, 2026 | 41.87 | 42.52 | 41.20 | 42.10 | 839024.0 |
| Sep 18, 2026 | 42.57 | 43.27 | 41.90 | 42.02 | 3.821M |
| Sep 17, 2026 | 42.59 | 43.01 | 42.10 | 42.74 | 641414.0 |
| Sep 16, 2026 | 42.28 | 43.05 | 42.06 | 42.21 | 1.599M |
| Sep 15, 2026 | 41.64 | 42.19 | 40.94 | 42.17 | 1.213M |
| Sep 14, 2026 | 41.93 | 42.25 | 41.48 | 41.54 | 1.044M |
| Sep 11, 2026 | 41.30 | 41.72 | 40.92 | 41.52 | 1.123M |
| Sep 10, 2026 | 41.26 | 41.72 | 40.93 | 41.10 | 736834.0 |
| Sep 09, 2026 | 42.01 | 42.40 | 41.23 | 41.62 | 1.133M |
| Sep 08, 2026 | 42.20 | 43.25 | 41.56 | 42.07 | 1.778M |
| Sep 04, 2026 | 41.50 | 42.34 | 41.36 | 42.25 | 662547.0 |
| Sep 03, 2026 | 42.93 | 43.49 | 41.40 | 41.86 | 1.101M |
| Sep 02, 2026 | 41.31 | 43.02 | 41.25 | 42.86 | 1.167M |
| Sep 01, 2026 | 39.38 | 41.49 | 39.38 | 41.25 | 894900.0 |
| Aug 31, 2026 | 38.97 | 39.74 | 38.97 | 39.38 | 560160.0 |
| Aug 28, 2026 | 39.69 | 39.69 | 39.13 | 39.21 | 590218.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Liquidia Corp. | 28.64 |
| Pfizer Inc. | 27.80 |
| Bristol Myers Squibb Co. | 61.15 |
| Repligen Corp. | 181.70 |
| Johnson & Johnson | 256.03 |
Price Related Metrics
| PE Ratio | 12.85 |
| PS Ratio | 2.426 |
| Price to Book Value | 2.306 |
| Price to Free Cash Flow | 6.937 |
| Earnings Yield | 7.78% |
| Market Cap | 2.304B |
| Operating PE Ratio | 10.09 |
| Normalized PE Ratio | 12.85 |